Data as of Aug 01
| -0.001 / -0.41%|
The 2 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 0.88, with a high estimate of 1.00 and a low estimate of 0.75. The median estimate represents a +264.58% increase from the last price of 0.24.
The current consensus among 2 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.